Trending Stories


From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.

MedAxiom Announces Industry Partnership with Westcove Partners

Partner News | Published: Monday, March 8, 2021

Westcove Partners (“Westcove”), a leading healthcare-focused investment bank that specializes in advising its clients through mergers & acquisitions, debt and equity financings, as well as other complex corporate finance transactions.


ScImage Receives Enabling Technology Leadership Award

Partner News | Published: Friday, February 26, 2021

ScImage, Inc., a leading provider of Enterprise Imaging solutions, announces it has received Frost & Sullivan’s 2020 North America Enabling Technology Leadership Award for its Cloud-based Enterprise Imaging Solutions.


HHS Announces Flexibility on Reporting Deadline For Provider Relief Fund Recipients

News | Published: Tuesday, January 19, 2021

The U.S. Department of Health and Human Services (HHS) on Jan. 15 announced that it is amending the reporting timeline for the Provider Relief Fund Program (PRF) in response to the recent passage of the Coronavirus Response and Relief Supplemental Appropriations Act. 


Genetesis Applauds CMS’s MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices

Partner News | Published: Wednesday, January 13, 2021

The Centers for Medicare & Medicaid Services (CMS) announced the establishment of the Medicare Coverage of Innovative Technology (MCIT) pathway, to bring new and innovative technologies to beneficiaries

ScImage Founder/CEO Reflects on 2020

Partner News | Published: Tuesday, January 12, 2021

ScImage, Inc., a leading provider of Enterprise Imaging solutions, announces significant expansion of deploying end-to-end diagnostic imaging workflows entirely in the Cloud for Cardiology, Vascular,

CardioFlux Magnetocardiograph Case Studies

Partner News | Published: Wednesday, January 6, 2021

Magnetocardiography (MCG) has been assessed over the last 30 years as a rapid diagnostic tool for various forms of cardiac pathophysiology. MCG is able to detect and discern miniscule differences in the magnetic fields generated by the heart’s natural pacemaker activity. These fields have previously been shown to change with cardiac ischemia due to dysfunction of the ion channels responsible for repolarization and depolarization of the myocardium.


Congress Approves $900B COVID-19 Relief Package, Year-End Spending Deal

News | Published: Monday, December 21, 2020

Congressional leaders finalized a $900 billion COVID-19 relief package and $1.4 trillion omnibus spending bill on Dec. 20, narrowly averting a government shutdown by passing a 24-hour continuing resolution to complete action on the catch-all appropriations and pandemic relief measure. While the process has been beset by delays, House and Senate leaders approved the package on Dec. 21. President Trump has until Dec. 28 to sign the legislation.


4 things to consider as you implement your Cardiovascular outmigration strategy

Partner News | Published: Wednesday, December 16, 2020

By Marc Toth, Vice President of Cardiovascular Services, Atlas Healthcare Partners and Meredith Banasiak, EDAC, Director of Research, Boulder Associates, Inc. It is anticipated that by 2030, 82% of all

Transforming CV Care, Together: MedAxiom’s Top 12 Resources of 2020

News | Published: Wednesday, December 16, 2020

MedAxiom’s support of the cardiovascular community is stronger than ever in 2020. As we near the end of the year, we want to reflect on and highlight the most valuable resources for transforming cardiovascular care. We hope that we were able to inform and support you and your organizations with tools for success, including webinars, videos, publications, resource “hubs” and more!


FDA Awards Genetesis Breakthrough Device Designation for CardioFlux® Imaging Technology

Partner News | Published: Tuesday, December 15, 2020

Genetesis, Inc., a MedAxiom partner, announced today that its flagship product, CardioFlux®, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for the